Alcentra Capital Corp. (NASDAQ:ABDC) hit a new 52-week low on Tuesday after an insider sold shares in the company. The company traded as low as $7.17 and last traded at $7.31, with a volume of 193400 shares trading hands. The stock had previously closed at $7.35.

Specifically, Director Paul J. Echausse sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $7.45, for a total value of $74,500.00. Following the completion of the transaction, the director now owns 58,946 shares of the company’s stock, valued at $439,147.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 4.96% of the stock is currently owned by company insiders.

A number of brokerages have recently commented on ABDC. Raymond James Financial, Inc. cut shares of Alcentra Capital Corp. from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Keefe, Bruyette & Woods set a $13.00 price objective on shares of Alcentra Capital Corp. and gave the stock a “hold” rating in a research note on Sunday, August 6th. UBS AG cut shares of Alcentra Capital Corp. from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Rowe cut shares of Alcentra Capital Corp. from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Finally, ValuEngine cut shares of Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $12.83.

The stock has a market cap of $104.13, a price-to-earnings ratio of 4.93 and a beta of 0.68.

Alcentra Capital Corp. (NASDAQ:ABDC) last announced its quarterly earnings results on Monday, November 6th. The asset manager reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.01. The company had revenue of $7.61 million for the quarter. Alcentra Capital Corp. had a negative net margin of 2.25% and a positive return on equity of 11.32%. analysts expect that Alcentra Capital Corp. will post 1.32 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 4th. Shareholders of record on Friday, December 29th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 13.68%. The ex-dividend date of this dividend is Thursday, December 28th. Alcentra Capital Corp.’s payout ratio is 283.33%.

Alcentra Capital Corp. announced that its board has authorized a share buyback program on Monday, November 6th that allows the company to buyback $2.50 million in outstanding shares. This buyback authorization allows the asset manager to purchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Several large investors have recently bought and sold shares of ABDC. Muzinich & Co. Inc. boosted its stake in shares of Alcentra Capital Corp. by 34.7% in the 2nd quarter. Muzinich & Co. Inc. now owns 610,164 shares of the asset manager’s stock valued at $8,292,000 after purchasing an additional 157,251 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Alcentra Capital Corp. by 45.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 242,865 shares of the asset manager’s stock valued at $3,300,000 after purchasing an additional 76,115 shares during the last quarter. Salem Investment Counselors Inc. bought a new stake in shares of Alcentra Capital Corp. in the 2nd quarter valued at $646,000. Stephens Inc. AR bought a new stake in shares of Alcentra Capital Corp. in the 3rd quarter valued at $253,000. Finally, Salzhauer Michael boosted its stake in shares of Alcentra Capital Corp. by 62.6% in the 2nd quarter. Salzhauer Michael now owns 47,292 shares of the asset manager’s stock valued at $643,000 after purchasing an additional 18,200 shares during the last quarter. 30.95% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Alcentra Capital Corp. (ABDC) Reaches New 52-Week Low Following Insider Selling” was first published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/11/14/alcentra-capital-corp-abdc-reaches-new-52-week-low-following-insider-selling.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.